Clinical Trial Update: Dose-Finding Pilot Study of ACTH in Patients With Idiopathic Membranous Nephropathy [Phase 1]

View source ↗

Summary

A Phase 1 dose-finding pilot study of adrenocorticotropic hormone (ACTH) in idiopathic membranous nephropathy has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Membranous Nephropathy

Drugs mentioned

• ACTH (adrenocorticotropic hormone)

Snippet

Sponsor: Mayo Clinic | Conditions: Idiopathic Membranous Nephropathy | Phase 1 | Status: COMPLETED